lidocaine has been researched along with 2019 Novel Coronavirus Disease in 15 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compound lidocaine/prilocaine cream combined with tetracaine may be a more effective approach for preventing coughing and stabilising circulation during extubation following general anaesthesia." | 9.69 | Compound lidocaine/prilocaine cream combined with tetracaine prevents cough caused by extubation after general anaesthesia: a randomised controlled trial. ( Gao, J; Li, T; Li, Y; Wang, M; Zhang, E; Zhang, H; Zhang, L; Zhao, X, 2023) |
| "Compound lidocaine/prilocaine cream combined with tetracaine may be a more effective approach for preventing coughing and stabilising circulation during extubation following general anaesthesia." | 5.69 | Compound lidocaine/prilocaine cream combined with tetracaine prevents cough caused by extubation after general anaesthesia: a randomised controlled trial. ( Gao, J; Li, T; Li, Y; Wang, M; Zhang, E; Zhang, H; Zhang, L; Zhao, X, 2023) |
| "The main objective of this study is to evaluate the effect of intravenous lidocaine on gas exchange and inflammation in acute respiratory distress syndrome due or not to Covid-19 pneumonia." | 5.41 | Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial. ( Aberkane, O; Becker, G; Chamaraux-Tran, TN; Glady, L; Harlay, ML; Hecketsweiler, S; Julians, M; Lefebvre, F; Muller, C; Muller, M; Pottecher, J; Romoli, A; Schneider, F; Tawk, M, 2021) |
| "Severe cases of Coronavirus Disease 2019 (COVID-19) that require admission to the Intensive Care Unit (ICU) and mechanical ventilation assistance show a high mortality rate with currently few therapeutic options available." | 1.91 | Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection. ( Baumeister, E; Correger, E; Docena, G; Elizagaray, ML; Mazitelli, I; Pontoriero, A; Raimondi, C; Rumbo, M, 2023) |
| "Oral manifestations of coronavirus disease 2019 (COVID-19), including ulcers, herpetiform lesions, macules, and petechiae, among others, are becoming increasingly recognized, but there is little guidance on their treatment." | 1.72 | Conservative treatment with mouthwashes followed by tongue photo biomodulation therapy in Covid-19: a case report. ( Asif, A; Chaughtai, S; Chaughtai, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 15 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barman, R | 1 |
| Clark, K | 1 |
| Olatoye, O | 1 |
| Hasan, D | 1 |
| Shono, A | 1 |
| van Kalken, CK | 1 |
| van der Spek, PJ | 1 |
| Krenning, EP | 1 |
| Kotani, T | 1 |
| Elizagaray, ML | 1 |
| Mazitelli, I | 1 |
| Pontoriero, A | 1 |
| Baumeister, E | 1 |
| Docena, G | 1 |
| Raimondi, C | 1 |
| Correger, E | 1 |
| Rumbo, M | 1 |
| Huo, J | 1 |
| Chen, C | 1 |
| Gao, D | 1 |
| Yang, L | 1 |
| Qu, R | 1 |
| Jiang, H | 1 |
| Chen, X | 2 |
| Guo, Y | 1 |
| Zhu, S | 1 |
| Ou, D | 1 |
| Zhao, L | 1 |
| Chaughtai, S | 1 |
| Chaughtai, Z | 1 |
| Asif, A | 1 |
| Zhang, E | 1 |
| Zhao, X | 1 |
| Li, T | 3 |
| Wang, M | 1 |
| Gao, J | 1 |
| Zhang, H | 1 |
| Li, Y | 1 |
| Zhang, L | 1 |
| Liu, X | 1 |
| Zheng, F | 1 |
| Tian, L | 1 |
| Zhang, Z | 1 |
| Ren, Z | 1 |
| Chen, W | 1 |
| Li, K | 1 |
| Sheng, J | 1 |
| Aminnejad, R | 1 |
| Salimi, A | 1 |
| Saeidi, M | 1 |
| Ali, ZA | 1 |
| El-Mallakh, RS | 1 |
| Finnerty, DT | 1 |
| Buggy, DJ | 1 |
| Kanodia, A | 1 |
| Srigyan, D | 1 |
| Sikka, K | 1 |
| Choudhary, A | 1 |
| Choudekar, A | 1 |
| Mittal, S | 1 |
| Bhopale, SA | 1 |
| Dar, L | 1 |
| Thakar, A | 1 |
| Jain, A | 1 |
| Lamperti, M | 1 |
| Doyle, DJ | 1 |
| Turcotte, JJ | 1 |
| Petre, BM | 1 |
| Jones, CM | 1 |
| Gelfand, JM | 1 |
| Giardino, FR | 1 |
| Cuomo, R | 1 |
| Sisti, A | 1 |
| Han, J | 1 |
| Giuseppe, N | 1 |
| Grimaldi, L | 1 |
| Muller, M | 1 |
| Lefebvre, F | 1 |
| Harlay, ML | 1 |
| Glady, L | 1 |
| Becker, G | 1 |
| Muller, C | 1 |
| Aberkane, O | 1 |
| Tawk, M | 1 |
| Julians, M | 1 |
| Romoli, A | 1 |
| Hecketsweiler, S | 1 |
| Schneider, F | 1 |
| Pottecher, J | 1 |
| Chamaraux-Tran, TN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia[NCT04609865] | Phase 3 | 100 participants (Anticipated) | Interventional | 2020-11-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lidocaine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
Topics: Adenosine Triphosphate; Anti-Inflammatory Agents; COVID-19; Critical Care; Cytokine Release Syndrome | 2022 |
2 trials available for lidocaine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Compound lidocaine/prilocaine cream combined with tetracaine prevents cough caused by extubation after general anaesthesia: a randomised controlled trial.
Topics: Airway Extubation; Anesthesia, General; Anesthetics, Local; Cough; COVID-19; Double-Blind Method; Ep | 2023 |
Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; | 2021 |
12 other studies available for lidocaine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Short-Term Lidocaine Infusion as a Nonsedative Option to Maintain Ventilator Synchrony During Opioid Tapering in a COVID-19 Patient.
Topics: Analgesics, Opioid; COVID-19; Humans; Infusions, Intravenous; Lidocaine; SARS-CoV-2; Ventilators, Me | 2022 |
Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
Topics: Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Treatment; Cytokines; Dexamethasone; Epithelial Ce | 2023 |
Ultrasound-Guided Capsular Thyroid Injection Therapy With Dexamethasone and Lidocaine Mixture for Subacute Thyroiditis: A Single-Center Study.
Topics: COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Hypothyroidism; Lidocaine; Pain; Thyroidit | 2023 |
Conservative treatment with mouthwashes followed by tongue photo biomodulation therapy in Covid-19: a case report.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Conservative Treatment; COVID-19; | 2022 |
Lidocaine inhibits influenza a virus replication by up-regulating IFNα4 via TBK1-IRF7 and JNK-AP1 signaling pathways.
Topics: Animals; Antiviral Agents; COVID-19; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Inf | 2023 |
Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19).
Topics: Airway Extubation; Anesthesiology; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; C | 2020 |
Nebulized Lidocaine in COVID-19, An Hypothesis.
Topics: Administration, Inhalation; Anesthetics, Local; Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Tr | 2020 |
A novel role for lidocaine in COVID-19 patients?
Topics: Anesthetics, Local; Coronavirus Infections; COVID-19; Cytokines; Extracellular Traps; Humans; Lidoca | 2020 |
Topical lignocaine anaesthesia for oropharyngeal sampling for COVID-19.
Topics: Adult; Anesthesia; COVID-19; Humans; Lidocaine; Oropharynx; RNA, Viral; SARS-CoV-2 | 2021 |
Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.
Topics: COVID-19; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Lidocaine; SARS-Co | 2021 |
Maintaining Access to Orthopaedic Surgery During Periods of Operating Room Resource Constraint: Expanded Use of Wide-Awake Surgery During the COVID-19 Pandemic.
Topics: Adult; Aged; Anesthesia, Local; Anesthetics, Local; COVID-19; Epinephrine; Female; Hemostatics; Huma | 2020 |
Taking care of healthcare workers during COVID-19 pandemic: does plastic surgery have a role?
Topics: Anesthetics, Local; Burnout, Professional; Collagen; COVID-19; Health Personnel; Humans; Infectious | 2020 |